复星和甲对青素诱导的相互作用模型:电生理学和分子研究
Zeynep Kasap Acungil1, Secil Erden Tayhan2, Nazan Goksen Tosun3
1Department of Physiotherapy and Rehabilitation, Faculty of Health Science, Tokat Gaziosmanpasa University, Tokat, Turkey. zeynep.kasap@gop.edu.tr.
Molecular neurobiology
|September 24, 2024
概括
单独的白醇并没有在模型中显著减少发作. 然而,当与甲结合时,它有效地降低了型活动,并调节了关键受体表达.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 是一种常见的慢性神经系统疾病,其特征是经常性发作.
- 复星在实验模型中显示出神经保护作用和降低型活动.
研究的目的:
- 为了研究单独或与甲联合使用的白醇对型的活性在青素诱导的模型中的影响.
- 分析对特定神经递质受体表达和血清S100B水平的影响.
主要方法:
- 在Wistar-albino大鼠 (n=40) 中使用青素诱导的模型的体内研究.
- 鼠被分为五组:盐水,青素,白醇,甲和白醇+甲.
- 进行了脑电图 (ECoG) 记录,并测量了海马体受体表达 (GABAα1,mGluR1/mGluR5,NMDAR1) 和血清S100B水平.
主要成果:
- 与青素组相比,单独的白醇并没有显著改变型活动.
- 甲和复星+甲的组合显著降低了峰值频率.
- 组合组显示了型活动的最显著减少,从记录的第20分钟开始.
- 与青素组相比,GABAα1受体表达增加,而mGluR1/mGluR5和NMDAR1受体表达在所有治疗组都下降.
- 与青素组相比,所有组的血清S100B水平都增加了.
结论:
- 在这种青素诱导的模型中,resveratrol单一治疗对降低型活动无效.
- 使用白醇和甲的联合治疗显著抑制了型活动.
- 联合治疗调节了关键受体表达,表明了对的协同神经保护机制.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
266
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
266
Antiepileptic Drugs: GABAergic Pathway Potentiators
341
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
341
Antiepileptic Drugs: Sodium Channel Blockers
452
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
452
Antiepileptic Drugs: Potassium Channel Activators
149
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
149
Antiepileptic Drugs: Calcium Channel Blockers
341
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
341
Arteries of the Lower Limbs
181
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
181


